Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study
Abstract
1. Introduction
2. Methods
3. Statistical Analysis
4. Results
5. Discussion
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Acknowledgments
Conflicts of Interest
References
- Forestier, J.; Rotes-Querol, J. Senile Ankylosing Hyperostosis of the Spine. Ann. Rheum. Dis. 1950, 9, 321–330. [Google Scholar] [CrossRef] [PubMed]
- Resnick, D.; Shaul, S.R.; Robins, J.M. Diffuse idiopathic skeletal hyperostosis (DISH): Forestier’s disease with extraspinal manifestations. Radiology 1975, 115, 513–524. [Google Scholar] [CrossRef] [PubMed]
- Mader, R.; Sarzi-Puttini, P.; Atzeni, F.; Olivieri, I.; Pappone, N.; Verlaan, J.-J.; Buskila, D. Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology 2009, 48, 1478–1481. [Google Scholar] [CrossRef] [PubMed]
- Resnick, D.; Niwayama, G. Radiographic and Pathologic Features of Spinal Involvement in Diffuse Idiopathic Skeletal Hyperostosis (DISH). Radiology 1976, 119, 559–568. [Google Scholar] [CrossRef] [PubMed]
- Clavaguera, T.; Reyner, P.; Valls, R.; de Cendra, E.; Rodríguez-Jimeno, M.C. Diffuse idiopathic skeletal hyperostosis: Can we identify a peripheral pattern? Reum. Clin. 2019, 15, 301–304. [Google Scholar] [CrossRef]
- Lee, W.; Kim, W.R.; Chang, M.C. Severe hip joint motion restriction in a patient with diffuse idiopathic skeletal hyperostosis: A case report. Medicine 2018, 97, e0652. [Google Scholar] [CrossRef]
- Hwang, J.; Hwang, D.-S.; Kang, C.; Lee, W.-Y.; Lee, G.-S.; Lee, J.-K.; Kim, Y.-K. Arthroscopic Treatment for Femoroacetabular Impingement with Extraspinal Diffuse Idiopathic Skeletal Hyperostosis. Clin. Orthop. Surg. 2019, 11, 275–281. [Google Scholar] [CrossRef]
- Bregeon, C.; Chevalier, J.; Bigorgne, J.C.; Renier, J.C. Ankylosing vertebral hyperostosis. Etiological investigations and search for a hypersecretion of growth hormone. Rev. Du Rhum. Mal. Osteo-Articul. 1973, 40, 319–327. [Google Scholar]
- Rogers, J.; Watt, I.; Dieppe, P. Palaeopathology of spinal osteophytosis, vertebral ankylosis, ankylosing spondylitis, and vertebral hyperostosis. Ann. Rheum. Dis. 1985, 44, 113–120. [Google Scholar] [CrossRef]
- Utsinger, P.D. Diffuse idiopathic skeletal hyperostosis. Clin. Rheum. Dis. 1985, 11, 325–351. [Google Scholar] [CrossRef]
- Kuperus, J.S.; de Gendt, E.E.A.; Oner, F.C.; de Jong, P.A.; Buckens, S.C.F.M.; van der Merwe, A.E. Classification criteria for diffuse idiopathic skeletal hyperostosis: A lack of consensus. Rheumatology 2017, 56, 1123–1134. [Google Scholar] [CrossRef]
- Crubézy, E.; Crubézy-Ibanez, E. Evaluation of diagnostic criteria for hyperostotic diseases on a series of skeletons. Epidemiological implications. Rev. Du Rhum. 1993, 60, 586–590. [Google Scholar]
- Mader, R.; Buskila, D.; Verlaan, J.-J.; Atzeni, F.; Olivieri, I.; Pappone, N.; Di Girolamo, C.; Sarzi-Puttini, P. Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: Back to square one. Rheumatology 2012, 52, 326–330. [Google Scholar] [CrossRef]
- Kuperus, J.S.; Oudkerk, S.F.; Foppen, W.; Hoesein, F.A.M.; Gielis, W.P.; Waalwijk, J.; Regan, E.A.; Lynch, D.A.; Oner, F.C.; De Jong, P.A.; et al. Criteria for Early-Phase Diffuse Idiopathic Skeletal Hyperostosis: Development and Validation. Radiology 2019, 291, 420–426. [Google Scholar] [CrossRef]
- Vandenbroucke, J.P.; von Elm, E.; Altman, D.G.; Gøtzsche, P.C.; Mulrow, C.D.; Pocock, S.J. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Int. J. Surg. 2014, 12, 1500–1524. [Google Scholar] [CrossRef] [PubMed]
- Resnick, D. Diffuse Idiopathic Skeletal Hyperostosis (DISH). In Bone and Joint Imaging; Resnick, M.D., Ed.; W.B Saunders Company: Philadelphia, PA, USA, 2005; pp. 378–387. [Google Scholar]
- Aydin, S.Z.; Can, M.; Alibaz-Oner, F.; Keser, G.; Kurum, E.; Inal, V.; Yazisiz, V.; Birlik, M.; Emmungil, H.; Atagündüz, M.P.; et al. A relationship between spinal new bone formation in ankylosing spondylitis and the sonographically determined Achilles tendon enthesophytes. Rheumatol. Int. 2015, 36, 397–404. [Google Scholar] [CrossRef]
- Mata, S.; Chhem, R.K.; Fortin, P.R.; Joseph, L.; Esdaile, J.M. Comprehensive radiographic evaluation of diffuse idiopathic skeletal hyperostosis: Development and interrater reliability of a scoring system. Semin. Arthritis Rheum. 1998, 28, 88–96. [Google Scholar] [CrossRef]
- Guldberg-Møller, J.; Terslev, L.; Nielsen, S.M.; Kønig, M.J.; Torp-Pedersen, S.T.; Torp-Pedersen, A.; Christensen, R.; Bliddal, H.; Ellegaard, K. Ultrasound pathology of the entheses in an age and gender stratified sample of healthy adult subjects: A prospective cross-sectional frequency study. Clin. Exp. Rheumatol. 2018, 37, 408–413. [Google Scholar]
- Hermann, K.G.A.; Bollow, M. Rethinking diffuse idiopathic skeletal hyperostosis. Rheumatology 2014, 53, 1917–1919. [Google Scholar] [CrossRef][Green Version]
- Mader, R. Diffuse idiopathic skeletal hyperostosis: Time for a change. J. Rheumatol. 2008, 35, 377–379. [Google Scholar]
- Mader, R.; Verlaan, J.-J.; Eshed, I.; Jacome, B.-A.; Puttini, P.S.; Atzeni, F.; Buskila, D.; Reinshtein, E.; Novofastovski, I.; Fawaz, A.; et al. Diffuse idiopathic skeletal hyperostosis (DISH): Where we are now and where to go next. RMD Open 2017, 3, e000472. [Google Scholar] [CrossRef] [PubMed]
- Mata, S.; Fortin, P.R.; Fitzcharles, M.-A.; Starr, M.R.; Joseph, L.; Watts, C.S.; Gore, B.; Rosenberg, E.; Chhem, R.K.; Esdaile, J.M. A Controlled Study of Diffuse Idiopathic Skeletal Hyperostosis Clinical Features and Functional Status. Medicine 1997, 76, 104–117. [Google Scholar] [CrossRef] [PubMed]
- Kagotani, R.; Yoshida, M.; Muraki, S.; Oka, H.; Hashizume, H.; Yamada, H.; Enyo, Y.; Nagata, K.; Ishimoto, Y.; Teraguchi, M.; et al. Prevalence of diffuse idiopathic skeletal hyperostosis (DISH) of the whole spine and its association with lumbar spondylosis and knee osteoarthritis: The ROAD study. J. Bone Miner. Metab. 2014, 33, 221–229. [Google Scholar] [CrossRef] [PubMed]
- Kim, B.S.; Moon, M.S.; Yoon, M.G.; Kim, S.T.; Kim, S.J.; Kim, M.S.; Kim, D.S. Prevalence of Diffuse Idiopathic Skeletal Hyperostosis Diagnosed by Whole Spine Computed Tomography: A Preliminary Study. Clin. Orthop. Surg. 2018, 10, 41–46. [Google Scholar] [CrossRef]
- Lee, W.; Reveille, J.D.; Davis, J.C.; Learch, T.J.; Ward, M.M.; Weisman, M.H. Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort. Ann. Rheum. Dis. 2007, 66, 633–638. [Google Scholar] [CrossRef] [PubMed]
- Castro, R.O.; Ugalde, P.F.; Villegas, M.C.C.; Gutiérrez, J.C.; Gomariz, E.M.; Montejo, P.Z.; Almodóvar, R.; Mendoza, J.M.; Torre-Alonso, J.C.; Masmitjá, J.G.; et al. Different clinical expression of patients with ankylosing spondylitis according to gender in relation to time since onset of disease. Data from REGISPONSER. Reumatol. Clin. 2013, 9, 221–225. [Google Scholar]
- Mader, R.; Verlaan, J.-J.; Buskila, D. Diffuse idiopathic skeletal hyperostosis: Clinical features and pathogenic mechanisms. Nat. Rev. Rheumatol. 2013, 9, 741–750. [Google Scholar] [CrossRef]
- Kiss, C.; Szilágyi, M.; Paksy, A.; Poór, G. Risk factors for diffuse idiopathic skeletal hyperostosis: A case–control study. Rheumatology 2002, 41, 27–30. [Google Scholar] [CrossRef]
- Mader, R.; Novofestovski, I.; Adawi, M.; Lavi, I. Metabolic Syndrome and Cardiovascular Risk in Patients with Diffuse Idiopathic Skeletal Hyperostosis. Semin. Arthritis Rheum. 2009, 38, 361–365. [Google Scholar] [CrossRef]
- Pillai, S.; Littlejohn, G. Metabolic Factors in Diffuse Idiopathic Skeletal Hyperostosis—A Review of Clinical Data. Open Rheumatol. J. 2014, 8, 116–128. [Google Scholar] [CrossRef]
- Lantsman, C.D.; Herman, A.; Verlaan, J.J.; Stern, M.; Mader, R.; Eshed, I. Abdominal fat distribution in diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis patients compared to controls. Clin. Radiol. 2018, 73, 910–915. [Google Scholar] [CrossRef] [PubMed]
Variable | |
---|---|
Sex, n (%) | |
Females | 41 (42.3) |
Males | 56 (57.7) |
Age at diagnosis, years | 65.6 (9.5) |
Age at onset, years | 58.2 (9.0) |
Comorbidities, n (%) | |
Type 2 diabetes | |
Yes | 24 (25.0) |
No | 72 (75.0) |
Dyslipidaemia | |
Yes | 35 (36.5) |
No | 61 (63.5) |
CVE 1 | |
Yes | 11 (11.5) |
No | 85 (88.5) |
AHT 2 | |
Yes | 49 (51.0) |
No | 47 (49.0) |
Resnick criteria, n (%) | |
Yes | 70 (72.2) |
No | 27 (27.8) |
Utsinger criteria, n (%) | |
Definite | 70 (72.2) |
Probable | 20 (20.6) |
Possible | 7 (7.2) |
Presenting symptoms, n (%) | |
Pain/limitation TS 3/LS 4 | 42 (43.8) |
Enthesitis | 23 (24.0) |
Radiological findings | 10 (10.4) |
Hip pain/limitation | 5 (5.2) |
Pain/limitation CS 5 | 16 (16.7) |
Enthesitis, n (%) | |
Yes | 39 (40.2) |
No | 58 (59.8) |
Patterns, n 68 (%) | |
Peripheral | 20 (29.4) |
Axial | 21 (30.9) |
Mixed | 27 (39.7) |
Axial involvement n (%) | |
CS 5 (n = 64) | |
Affected | 37 (57.8) |
Not affected | 27 (42.2) |
TS 3 (n = 92) | |
Affected | 85 (92.4) |
Not affected | 7 (7.6) |
LS 4 (n = 89) | |
Affected | 50 (56.2) |
Not affected | 39 (43.8) |
Extraspinal involvement, n (%) | |
Elbow [olecranon] (n = 44) | |
Affected | 30 (68.2) |
Not affected | 14 (31.8) |
Hip [acetabular excrescences] (n = 82) | |
Affected | 42 (51.2) |
Not affected | 40 (48.8) |
Major Trochanter (n = 80) | |
Affected | 65 (81.3) |
Not affected | 15 (18.8) |
Knees (sup/inf patella, tibial tuberosity) (n = 65) | |
Affected | 43 (66.2) |
Not affected | 22 (33.8) |
Achilles tendon insertion (n = 54) | |
Affected | 43 (79.6) |
Not affected | 11 (20.4) |
Plantar calcaneus (n = 52) | |
Affected | 39 (75.0) |
Not affected | 13 (25.0) |
PATTERNS TYPE | PP | AP | MP | p-Value | |||
---|---|---|---|---|---|---|---|
Age Dg 1, years (n/mean/SD) | 20 | 62.05 (11.81) | 21 | 68.14 (8.76) | 27 | 66.30 (8.19) | 0.119 |
Age at onset, years (n/mean/SD) | 17 | 53.88 (5.31) # | 15 | 60.53 (10.27) | 21 | 60.05 (7.36) # | 0.036 |
Sex (n/%) | 0.004 | ||||||
Females | 14 | 70.0% a | 4 | 19.0% b | 10 | 37.0% a,b | |
Males | 6 | 30.0% a | 17 | 81.0% b | 17 | 63.0% a,b | |
Diagnostic delay, years (n/mean/SD) | 17 | 5.53 (8.83) | 15 | 7.33 (8.16) | 21 | 6.52 (8.24) | 0.832 |
Comorbidities (n/%) | |||||||
Type 2 diabetes | 0.419 | ||||||
Yes | 3 | 15.8% | 7 | 33.3% | 8 | 29.6% | |
No | 16 | 84.2% | 14 | 66.7% | 19 | 70.4% | |
Dyslipidaemia | 0.739 | ||||||
Yes | 6 | 31.6% | 9 | 42.9% | 11 | 40.7% | |
No | 13 | 68.4% | 12 | 57.1% | 16 | 59.3% | |
CVE 2 | 0.001 | ||||||
Yes | 1 | 5.3% a,b | 7 | 33.3% b | 0 | 0.0% a | |
No | 18 | 94.7% a,b | 14 | 66.7% b | 27 | 100.0% a | |
AHT 3 | 0.123 | ||||||
Yes | 7 | 36.8% | 8 | 38.1% | 17 | 63.0% | |
No | 12 | 63.2% | 13 | 61.9% | 10 | 37.0% | |
Presenting symptom (n/%) | 0.007 | ||||||
Pain/limitation TS 4/LS 5 | 4 | 20.0% a | 10 | 47.6% a | 10 | 38.5% a | |
Clin enthesopathy | 11 | 55.0% a | 1 | 4.8% b | 9 | 34.6% a | |
Rx findings 6 | 1 | 5.0% a | 6 | 28.6% a | 1 | 3.8% a | |
Hip pain/limitation | 2 | 10.0% a | 1 | 4.8% a | 1 | 3.8% a | |
Pain/limitation CS 7 | 2 | 10.0% a | 3 | 14.3% a | 5 | 19.2% a | |
Clinical enthesopathy (n/%) | <0.001 | ||||||
Yes | 17 | 85.0% a | 5 | 23.8% b | 11 | 40.7% b | |
No | 3 | 15.0% a | 16 | 76.2% b | 16 | 59.3% b | |
Radiological findings (n/%) | |||||||
CS 7 (n = 45) | 0.020 | ||||||
Affected | 3 | 18.8% a | 6 | 60.0% a,b | 12 | 63.2% b | |
Not affected | 13 | 81.3% a | 4 | 40.0% a,b | 7 | 36.8% b | |
TS 4 (n = 63) | 0.059 | ||||||
Affected | 15 | 78.9% | 19 | 100.0% | 24 | 96.0% | |
Not affected | 4 | 21.1% | 0 | 0.0% | 1 | 4.0% | |
LS 5 (n = 63) | <0.001 | ||||||
Affected | 3 | 15.0% a | 12 | 66.7% b | 19 | 76.0% b | |
Not affected | 17 | 85.0% a | 6 | 33.3% b | 6 | 24.0% b | |
Hip (n = 63) | 0.035 | ||||||
Affected | 13 | 65.0% a | 5 | 26.3% b | 14 | 58.3% a,b | |
Not affected | 7 | 35.0% a | 14 | 73.7% b | 10 | 41.7% a,b |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Clavaguera, T.; Reyner, P.; Buxó, M.; Valls, M.; Armengol, E.; Juanola, X. Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study. Medicina 2021, 57, 1005. https://doi.org/10.3390/medicina57101005
Clavaguera T, Reyner P, Buxó M, Valls M, Armengol E, Juanola X. Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study. Medicina. 2021; 57(10):1005. https://doi.org/10.3390/medicina57101005
Chicago/Turabian StyleClavaguera, Teresa, Patrícia Reyner, Maria Buxó, Marta Valls, Eulàlia Armengol, and Xavier Juanola. 2021. "Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study" Medicina 57, no. 10: 1005. https://doi.org/10.3390/medicina57101005
APA StyleClavaguera, T., Reyner, P., Buxó, M., Valls, M., Armengol, E., & Juanola, X. (2021). Identifying Clinicoradiological Phenotypes in Diffuse Idiopathic Skeletal Hyperostosis: A Cross-Sectional Study. Medicina, 57(10), 1005. https://doi.org/10.3390/medicina57101005